Designer Drug Confusion: A Focus on MDMA
- 1 September 1986
- journal article
- research article
- Published by SAGE Publications in Journal of Drug Education
- Vol. 16 (3) , 287-302
- https://doi.org/10.2190/tw2b-2p4a-kgum-6102
Abstract
This article discusses the competing definitions and issues surrounding the various desgner drugs, but is primarily devoted t o an examination of MDMA, an increasingly popular substance often labeled as a designer drug. Also known as “Ecstasy” or “Adam,” MDMA possesses both stimulant and psychedelic properties which combine to produce a unique effect desired by many users. The authors offer a rationale for why interest in MDMA will continue to grow despite the drug's recent illegality and the increasing evidence of neurotoxicity. MDMA's recreational attraction and therapeutic potential are discussed. Much more research is necessary to address both the potential benefits and risks of this controversial substance.Keywords
This publication has 10 references indexed in Scilit:
- MDMA on the Street: Analysis Anonymous®Journal of Psychoactive Drugs, 1986
- Some Considerations on the Prevalence of MDMA UseJournal of Psychoactive Drugs, 1986
- Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve TerminalsScience, 1985
- Characteristics, Attitudes and Implications of Fentanyl Use Based on Reports from Self-Identified Fentanyl UsersJournal of Psychoactive Drugs, 1983
- MDA-ASSISTED PSYCHOTHERAPY WITH NEUROTIC OUTPATIENTSJournal of Nervous & Mental Disease, 1976
- The Love DrugJournal of Psychedelic Drugs, 1976
- Observations On The Phenomenology Of Consciousness ChangeJournal of Psychedelic Drugs, 1976
- Methylenedioxyamphetamine (MDA)–Subjective EffectsJournal of Psychedelic Drugs, 1974
- Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animalsToxicology and Applied Pharmacology, 1973
- A Fatal Case Involving MethylenedioxyamphetamineClinical Toxicology, 1972